Oracle Corporation Upgraded to $47 a Share; Doral Financial to Develop a Revised Capital Plan


Follow this company

Companies Mentioned

NYSE:NGVC / NYSE:BSX / NYSE:DRL / NYSE:ORCL
05/05/2014 [ACCESSWIRE]

Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) - For an in-depth report on Natural Grocers by Vitamin Cottage, Inc. follow: www.BullTrends.com/stockquote/NGVC

Shares of NGVC closed down 36.58% on about 2.5 million shares traded. The stock was one of the biggest decliners on the NYSE. The company recently announced that its nearly 90 stores will no longer sell dairy products that come from confinement dairies.

Boston Scientific Corporation (NYSE: BSX) - For an in-depth report on Boston Scientific Corporation follow: www.BullTrends.com/stockquote/BSX

Shares of BSX closed up a modest 1.67% on about 17.4 million shares traded. The stock was one of the most active stocks on the NYSE. The company reported strong first quarter financial results on April 29. The company met its own guidance of $1.75 – $1.8 billion for the quarter, but sales were $30 million short of the Reuters’ consensus estimate of $1.8 billion.

Doral Financial Corporation (NYSE: DRL) - For an in-depth report on Doral Financial Corporation follow: www.BullTrends.com/stockquote/DRL

Shares of DRL down 62.02% on nearly 2.4 million shares traded making it one of the biggest decliners on the NYSE. The stock even hit a new 52-week low of $3.33 during intra-day trading. The company recently said that it is in the process of developing a revised capital plan intended to enable the Company to remain in compliance with the requirements of its regulators.

Oracle Corporation (NYSE: ORCL) - For an in-depth report on Oracle Corporation follow: www.BullTrends.com/stockquote/ORCL

Shares of ORCL closed down modestly in the red on Friday with about 10.7 million shares traded. The stock was upgraded by Societe Generale to a “Buy” rating with the firm citing valuation and potential upside related to the upgrade cycle in the database business. The firm raised its price target for shares from $38 to $47.

 

Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.

COMMENTS

Leave a comment...
 * 

Your Name
 *